Nautilus Advisors LLC Johnson & Johnson Transaction History
Nautilus Advisors LLC
- $136 Billion
- Q2 2025
A detailed history of Nautilus Advisors LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Nautilus Advisors LLC holds 4,603 shares of JNJ stock, worth $878,482. This represents 0.52% of its overall portfolio holdings.
Number of Shares
4,603
Previous 4,638
0.75%
Holding current value
$878,482
Previous $769 Million
8.59%
% of portfolio
0.52%
Previous 0.64%
Shares
2 transactions
Others Institutions Holding JNJ
# of Institutions
4,669Shares Held
1.77BCall Options Held
18.4MPut Options Held
15.2M-
Vanguard Group Inc Valley Forge, PA237MShares$45.2 Billion0.61% of portfolio
-
Black Rock Inc. New York, NY198MShares$37.8 Billion0.67% of portfolio
-
State Street Corp Boston, MA133MShares$25.3 Billion0.78% of portfolio
-
Geode Capital Management, LLC Boston, MA60.6MShares$11.6 Billion0.67% of portfolio
-
Jpmorgan Chase & CO New York, NY54.1MShares$10.3 Billion0.7% of portfolio
About JOHNSON & JOHNSON
- Ticker JNJ
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,614,479,872
- Market Cap $499B
- Description
- Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...